logo
15:59 Apr 30

Syngene International Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
634.05
+5.15 (+0.82%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Syngene International Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
634.05
+5.15 (+0.82%)
15:59 Apr 30
Quality
image/svg+xml

46/100
Medium Financial Strength

Valuation
image/svg+xml

23/100
Expensive Valuation

Technical

31/100
Technically Bearish

Strength

8

Weakness

7

Opportunity

1

Threats

0

10.49 %

ROE %

7.30 %

ROA %

12.31

EPS

117.44

BVPS

13.62 %

Net Profit Margin

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales
2184.3 2604.2 3192.9 3488.6 3642.4
Operating Expenses +
1512.5 1808.1 2258.5 2474.2 2600.6
Raw Material
551.7 770.6 902.2 873.6 925.4
Increase Decrease in Cost
-25.2 -21.6 -42 56.6 17.1
Other Manufacturing Expense
0 0 0 0 0
Employee Cost
660.2 718.1 841.7 888.7 983.9
Miscellaneous Expenses
325.8 341 556.6 655.3 674.2
Operating Profit
671.8 796.1 934.4 1014.4 1041.8
Other Income
64.6 52.8 70.9 90.6 71.8
Depreciation
274.5 309.7 366.5 425.9 432.6
Interest
27.7 24.1 45.2 47.2 53.1
Profit before tax and exceptio..
434.2 515.1 593.6 631.9 627.9
Exceptional Items
35 -30.7 0 -11.1 32
PBT
469.2 484.4 593.6 620.8 659.9
Provision for Taxation
64.3 88.6 129.2 110.8 163.7
Net Profit
404.9 395.8 464.4 510 496.2
NET Profit after MI
404.9 395.8 464.4 510 496.2
EPS
10.11 9.82 11.51 12.69 12.35
Operating Profit Margin (%)
30.76 30.57 29.26 29.08 28.6
Net Profit Margin (%)
18.54 15.2 14.54 14.62 13.62

ShareHolding

Promoter

FII

Public

Mutual Funds

Other Institutions

All Data in Percentage (%)

Mar 25 Dec 24 Sep 24 Jun 24 Mar 24
Promoter 52.70 52.70 54.70 54.70 54.80
FII 19.50 20.60 20.70 20.60 20.90
MF 17.90 15.40 13.60 13.60 12.60
Public 6.00 6.80 6.70 7.40 8.20
Others 0.30 0.30 0.40 0.50 0.30
Others 3.60 4.20 3.90 3.20 3.20
Shareholder Shares Holding %
Research 360 logo

Download Our App On: